Table of Contents
ISRN Tropical Medicine
Volume 2013 (2013), Article ID 123858, 5 pages
http://dx.doi.org/10.1155/2013/123858
Research Article

Prevalence of Toxoplasma gondii and Associated Risk Factors among People Living with HIV at Gondar University Hospital, Northwest Ethiopia

1Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia
2Department of Medical Parasitology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia
3Institute of Virology, Faculty of Medicine, University of Leipzig, Johannisallee 30, 04103 Leipzig, Germany
4Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia

Received 18 June 2013; Accepted 10 July 2013

Academic Editors: R. Dey, R. E. Fretes, S. P. Lim, and S. Munga

Copyright © 2013 Dagnachew Muluye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Fayer, J. P. Dubey, and D. S. Lindsay, “Zoonotic protozoa: from land to sea,” Trends in Parasitology, vol. 20, no. 11, pp. 531–536, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. B. G. Gellin and R. Soave, “Coccidian infections in AIDS: toxoplasmosis, cryptosporidiosis, and isosporiasis,” Medical Clinics of North America, vol. 76, no. 1, pp. 205–234, 1992. View at Google Scholar · View at Scopus
  3. C. Contini, “Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient,” Parassitologia, vol. 50, no. 1-2, pp. 45–50, 2008. View at Google Scholar · View at Scopus
  4. J. E. Vidal, A. V. Hernandez, A. C. Penalva de Oliveira, R. F. Dauar, S. P. Barbosa Jr., and R. Focaccia, “Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era,” AIDS Patient Care and STDs, vol. 19, no. 10, pp. 626–634, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. P. A. Conrad, M. A. Miller, C. Kreuder et al., “Transmission of Toxoplasma: clues from the study of sea otters as sentinels of Toxoplasma gondii flow into the marine environment,” International Journal for Parasitology, vol. 35, no. 11-12, pp. 1155–1168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. B. T. E. Chan, R. N. Amal, M. I. Noor Hayati et al., “Seroprevalence of toxoplasmosis among migrant workers from different Asian countries working in Malaysia,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 39, no. 1, pp. 9–13, 2008. View at Google Scholar · View at Scopus
  7. J. Zufferey, A. Sugar, P. Rudaz, J. Bille, M. P. Glauser, and J. P. Chave, “Prevalence of latent toxoplasmosis and serological diagnosis of active infection in HIV-Positive patients,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 12, no. 8, pp. 591–595, 1993. View at Google Scholar · View at Scopus
  8. B. J. Luft and J. S. Remington, “Toxoplasmic encephalitis,” Journal of Infectious Diseases, vol. 157, no. 1, pp. 1–6, 1988. View at Google Scholar · View at Scopus
  9. T. Shimelis, M. Tebeje, E. Tadesse, B. Tegbaru, and A. Terefe, “Sero-prevalence of latent Toxoplasma gondii infection among HIV-infected and HIV-uninfected people in Addis Ababa, Ethiopia: a comparative cross-sectional study,” BMC Research Notes, vol. 2, article 213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Nissapatorn, “Toxoplasmosis in HIV/AIDS: a living legacy,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 40, no. 6, pp. 1158–1178, 2009. View at Google Scholar · View at Scopus
  11. B. J. Luft, R. Hafner, A. H. Korzun et al., “Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team,” The New England Journal of Medicine, vol. 329, pp. 995–1000, 1993. View at Google Scholar
  12. E. F. Torrey and R. H. Yolken, “Toxoplasma gondii and Schizophrenia,” Emerging Infectious Diseases, vol. 9, no. 11, pp. 1375–1380, 2003. View at Google Scholar · View at Scopus
  13. “BD FACS Count System User's Guide for Use with BD FACS Count CD4 Reagents,” 2008, http://www.bdbiosciences.com/external_files/pm/doc/manuals/live/web_enabled/339011.
  14. R. Shafiei, Z. Riazi, M. Sarvghad, M. G. Sharifdini, A. Mahmoodzadeh, and M. Hajia, “Prevalence of IgG and IgM anti-Toxoplasma gondii antibodies in HIV positive patients in northeast of Iran,” Iranian Journal of Pathology, vol. 6, no. 2, pp. 68–72, 2011. View at Google Scholar · View at Scopus
  15. V. Nissapatorn, C. Lee, K. F. Quek, C. L. Leong, R. Mahmud, and K. A. Abdullah, “Toxoplasmosis in HIV/AIDS patients: a current situation,” Japanese Journal of Infectious Diseases, vol. 57, no. 4, pp. 160–165, 2004. View at Google Scholar · View at Scopus
  16. P. O. Bessong and L. M. Mathomu, “Seroprevalence of HTLV1/2, HSV1/2 and Toxoplasma gondii among chronic HIV-1 infected individuals in rural northeastern South Africa,” African Journal of Microbiology Research, vol. 4, no. 23, pp. 2587–2591, 2010. View at Google Scholar · View at Scopus
  17. A. Pauwels, M. C. Meyohas, M. Eliaszewicz, C. Legendre, G. Mougeot, and J. Frottier, “Toxoplasma colitis in the acquired immunodeficiency syndrome,” American Journal of Gastroenterology, vol. 87, no. 4, pp. 518–519, 1992. View at Google Scholar · View at Scopus
  18. M. A. Abu-Madi, N. Al-Molawi, and J. M. Behnke, “Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar,” Parasites and Vectors, vol. 1, no. 1, article 39, 2008. View at Publisher · View at Google Scholar · View at Scopus